Ep Wealth Advisors, LLC Pds Biotechnology Corp Transaction History

Ep Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 22, 2023	BUY	$4.8 - $6.4 $48,993 - $65,324	10,207 New	10,207 $51,000
Q1 2023 Jun 05, 2023	BUY	$5.68 - $11.99 $160,954 - $339,760	28,337 Added 283.37%	38,337 $235,000
Q4 2022 Jun 12, 2023	SELL	$3.28 - $13.2 $92,266 - $371,316	-28,130 Reduced 73.38%	10,207 $134,000
Q3 2022 Dec 02, 2022	BUY	$2.97 - $5.79 $29,700 - $57,900	10,000 New	10,000 $30,000

4.32M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $62.6M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ep Wealth Advisors, LLC with notifications on news.